Novo Nordisk sells hit weight-loss drug in China—at fraction of US price
Ars Technica 2024-11-19
Summary:
As US struggles to afford GLP-1 drugs, the rest of the world sees much lower prices.
Link:
https://arstechnica.com/health/2024/11/novo-nordisk-sells-hit-weight-loss-drug-in-china-at-fraction-of-us-price/From feeds:
Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific MethodCyberlaw » Ars Technica
Music and Digital Media » Ars Technica